Deficiency in interleukin-18 promotes differentiation of brown adipose tissue resulting in fat accumulation despite dyslipidemia

J Transl Med. 2018 Nov 19;16(1):314. doi: 10.1186/s12967-018-1684-3.

Abstract

Background: The cytokine, interleukin-18 (IL-18), was originally identified as an interferon-γ-inducing proinflammatory factor; however, there is increasing evidence suggesting that it has non-immunological effects on physiological functions. We have previously investigated the potential pathophysiological relationship between IL-18 and dyslipidemia, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, which were mediated by lipid energy imbalance. Therefore, herein we focused on brown adipocytes (BAs) and brown adipose tissue (BAT) related to energy consumption as non-shivering thermogenesis.

Methods: Il18-/- male mice were generated on the C57Bl/6 background, and littermate C57Bl/6 Il18+/+ male mice were used as controls. To reveal the direct effect of IL-18, primary cell cultures derived from both mice were established. Moreover, for molecular analysis, microarray, quantitative reverse transcription PCR and western blotting were performed using 6 and 12 weeks old mice. To evaluate the short- and long-term effects of IL-18 on BAT, recombinant IL-18 was administered for 2 and 12 weeks, respectively.

Results: Compared with Il18+/+ mice, BAT of Il18-/- mice showed earlier differentiation and lipid accumulation. To examine the direct effect of IL-18 on BAT, BA cell cultures were established. Myogenic factor 5-expressing adipose precursor cells were extracted from Il18+/+ and Il18-/- mice. PR domain containing 16 (PRDM16), a differentiation inducer, was strongly expressed in Il18-/- BAs, and uncoupling protein 1, a thermogenic and differentiation marker, was upregulated, resulting in the promotion of BA differentiation. Moreover, PRDM16-dependent and independent molecules related to BAT function, such as fibroblast growth factor 21, were activated. These findings were confirmed by comparing Il18+/+ and Il18-/- mice at 6 and 12 weeks of age. Additional analyses of the molecular mechanisms influencing the 'Quantity of adipocytes' identified three associated genes, apolipoprotein C3 (Apoc3), insulin-induced gene 1 (Insig1) and vitamin D (1,25-dihydroxyvitamin D3) receptor (Vdr). Intravenous administration of IL-18 not only significantly improved the expression of some of these genes, but it also significantly decreased the adipocytes' size.

Conclusions: This study demonstrated the critical function of IL-18 in differentiation and lipid metabolism in BAs. Furthermore, IL-18 may contribute to novel treatments by improving the energy imbalance.

Keywords: Adipogenesis; Brown adipocytes; Brown adipose tissue; Interleukin-18; Interleukin-18 knockout; Lipid metabolism.

MeSH terms

  • Adipogenesis / drug effects
  • Adipose Tissue, Brown / drug effects
  • Adipose Tissue, Brown / growth & development
  • Adipose Tissue, Brown / pathology*
  • Adiposity*
  • Animals
  • Cell Differentiation* / drug effects
  • Dyslipidemias / metabolism*
  • Dyslipidemias / pathology*
  • Fatty Liver / pathology
  • Interleukin-18 / deficiency*
  • Interleukin-18 / metabolism
  • Lipid Metabolism / drug effects
  • Male
  • Mice, Inbred C57BL
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Stem Cells / drug effects
  • Stem Cells / metabolism
  • Thermogenesis / drug effects

Substances

  • Interleukin-18
  • Recombinant Proteins